Sept. 17, 2021 – A FDA advisory panel on Friday voted against approving third doses of Pfizer’s COVID-19 vaccine for younger Americans, but did unanimously agree to recommend boosters for seniors and others at high risk of severe outcomes from the coronavirus. ]
It was also a rebuff to the Biden administration, which announced that boosters would be rolled out to the general public beginning Monday, before the FDA had cleared them. The FDA Vaccines and Related Biological Products Advisory Committee’s vote on Pfizer’s original request was split, with 16 members saying there was not enough evidence to support approval of third doses, and two members voting in favor of approval. The FDA is not committed to following the committee’s recommendation, although it often does.
The approved motion specifies support for third doses for people over the age of 65 and anyone who is at high risk because of their occupation—such as health care workers, or because of underlying disease.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
COVID-19 Vaccines Won’t Affect Your Sexual Performance, but COVID-19 MightJust in case you were wondering. I like your choice of that photo. Very fitting. mood😑
Source: SELFmagazine - 🏆 478. / 51 Read more »
FDA Panel Weighs Covid-19 Booster Shots as Health Officials Debate NeedThe Biden administration’s push to introduce widespread vaccine boosters faces a test as a Food and Drug Administration advisory panel meets to weigh evidence on the extra shots, a topic that has divided federal health officials. good luck Clown world What is there to weigh here. Either the science supports it or it doesn’t
Source: WSJ - 🏆 98. / 63 Read more »
FDA Advisory Panel Votes Not to Recommend Covid Booster for People 16 and OlderThe Biden administration’s push to introduce widespread vaccine boosters hit a roadblock at a Food and Drug Administration advisory panel, which could still consider a narrower recommendation. The same people who have been screaming TRUST THE SCIENCE are going to start screaming that the FDA is wrong... Watch. 👀 Yet another major issue Biden was completely wrong on.
Source: WSJ - 🏆 98. / 63 Read more »
FDA panel is first key test for Biden COVID-19 booster planGovernment advisers are debating whether to recommend extra doses of the Pfizer vaccine, a key step toward the Biden administration's plan to dispense COVID-19 booster shots. Scientists have been divided over the need for boosters and who should get them. The Delta variant was from December, 2020. This should be a no-brainer right now. Think more as clinicians and practitioners than researchers. Science is now a debate and not based off evidence or facts. Let that sink in.
Source: AP - 🏆 728. / 51 Read more »
FDA advisers vote to oppose Pfizer/BioNTech COVID-19 vaccine boosterA panel of outside advisers to the U.S. Food and Drug Administration on Friday voted against approval of a booster dose of the Pfizer Inc /BioNTech SE COVID-19 vaccine for people aged 16 and older. Wrong headline here. They voted against it for people as young as 16. They have not yet voted on it for adults 60 and older and those with compromised immunity.
Source: Reuters - 🏆 2. / 97 Read more »
Coronavirus update: FDA booster meeting and Covid-19 vaccine newsThe Food and Drug Administration's advisory committee is meeting today to discuss booster doses of coronavirus vaccine. Follow here for the latest news. 60+ should get 3rd shot. Period. This is NOT following the science...
Source: cnnbrk - 🏆 393. / 55 Read more »